# Effect of Chronic Viral Hepatitis on the Pharmacokinetics of NRL972.

> **NCT00915057** · PHASE2 · COMPLETED · sponsor: **Norgine** · enrollment: 100 (estimated)

## Conditions studied

- Hepatitis, Viral, Human

## Interventions

- **DRUG:** NRL972

## Key facts

- **NCT ID:** NCT00915057
- **Lead sponsor:** Norgine
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2009-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00915057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00915057, "Effect of Chronic Viral Hepatitis on the Pharmacokinetics of NRL972.". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00915057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*